FOXM1 and cancer: Despite its role in cancer being acknowledged in literature [5,15], FOXM1 is altered in only 3% of all human cancer genomes (collected in the TCGA Pan-Cancer Atlas), with amplifications being the most common event (Figure 1B), followed by somatic point mutations.